More
    Guided Solutions - Connecting Talent With Innovation/div>

    Ciliatech wins CE mark for an eye implant for treating glaucoma

    Ciliatech announced it received CE mark approval for its Intercil uveal spacer, an eye implant for treating glaucoma. The Chavanod, France-based company labeled Intercil as...

    Brightonix wins FDA nod for flagship PET imaging system

    Brightonix Imaging announced its flagship Pharos positron emission tomography (PET) scanner received FDA clearance. Pharos, a state-of-the-art clinical PET system, offers high-quality imaging as part...

    NeuroOne’s nerve ablation system secures FDA clearance

    NeuroOne Medical Technologies has obtained 510(k) clearance from the US Food and Drug Administration (FDA) for its OneRF trigeminal nerve ablation system to treat...

    Onward wins FDA IDE for ARC-IM spinal cord stimulation system

    Onward Medical announced it received FDA investigational device exemption (IDE) for its ARC-IM system. ARC-IM, an implanted neuromodulation platform, delivers targeted and personalized spinal cord...

    SpinaFX’s Triojection system wins FDA breakthrough device designation

    The FDA has granted breakthrough device designation to SpinaFX Medical’s Triojection system, a minimally invasive treatment for contained lumbar disc herniations. Triojection is an image-guided...

    DeepSight receives first FDA clearance for NeedleVue LC1 Ultrasound System

    DeepSight Technology announced it received FDA 510(k) clearance for its NeedleVue LC1 ultrasound system. The company said clearance marks an important step forward in the...

    FDA grants investigational device exemption to Myra Vision’s Calibreye

    Myra Vision announced that it received FDA investigational device exemption (IDE) approval for its Calibreye system. The Shifamed portfolio company can now initiate its ADAPT...

    Instylla earns FDA premarket nod for hydrogel embolic system

    Instylla received FDA premarket approval (PMA) for its flagship Embrace hydrogel embolic system (HES). The Bedford, Massachusetts-based company received approval for Embrace for the embolization...

    Nyxoah wins FDA approval for sleep apnea neuromod system

    Nyxoah received FDA approval for its Genio neuromodulation device for treating sleep apnea. Genio utilises an implanted electrode around the hypoglossal nerve, stimulating the tongue...

    Latest articles